RT Conference Proceedings
T1 Extended follow-up of DURVAST trial: A phase II study evaluating durvalumab treatment in HIV-1-infected patients with solid tumours by the Spanish lung cancer group
A1 Gonzalez Cao, M.
A1 Moran, T.
A1 Dalmau, J.
A1 Garcia-Corbacho, J.
A1 Bernabe, R.
A1 Juan Vidal, O. J.
A1 de Castro Carpeno, J.
A1 Blanco, R.
A1 Drozdowskyj, A.
A1 Meyerhans, A.
A1 Blanco, J.
A1 Prado, J. G.
A1 Clotet, B.
A1 Massuti Sureda, B.
A1 Provencio Pulla, M.
A1 Molina-Vila, M. A.
A1 Martinez-Picado, J.
A1 Rosell Costa, R.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/27214
UL https://hdl.handle.net/10668/27214
LA en
DS RISalud
RD Apr 17, 2025